But in the poor prognosis groups, like ZAP70-high and 17q-patients, the nine-gene risk score was significantly higher than that in the low-risk group, and we found that the low expression of SLAMF1 in CLL was associated with ZAP70-high expression. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.